gsk glp 1 agonist The promise of GLP-1 receptor agonists for neurodegenerative diseases GLP-1 Agonists - What is
Description
Bjerre Knudsen, L
The case study reveals that following the administration of semaglutide, the patient exhibited a 20-point reduction in his Alcohol Use Disorders Identification Test (AUDIT) score and a marked reduction in alcohol use, including binge-drinking episodes
This is not an isolated problem
doi: 10.3233/JAD-210256 [DOI] [PubMed] [Google Scholar] 236
